Deep Tech Startups

RetMap develops next-generation electroretinography sensors and diagnostic medical devices for screening, diagnosis, and treatment of neurodegenerative eye conditions. The company serves ophthalmologists and clinicians seeking to detect and manage retinal diseases and prevent vision loss.

1 investor

Revadix develops first-in-class small molecule therapies targeting the EPAC1 signalling pathway to treat atrial fibrillation, addressing the underlying disease mechanism rather than symptoms. Its lead asset AM-001 is entering IND-enabling studies while a second EPAC1-targeting program is in lead optimization, aimed at cardiac arrhythmia patients.

1 investor

Revagenix is a precision-therapeutics company that develops drugs for serious chronic diseases, starting from the underlying biology and unmet clinical needs. Its lead program, Rev-56, is an inhaled therapy with a novel mechanism of action designed for non-CF bronchiectasis (NCFB).

1 investor

Revascular Bio develops cell therapy treatments using vascular endothelial stem cells to address diseases caused by vascular dysfunction, including chronic wounds, severe limb ischemia, and genetic blood disorders. The company targets intractable diseases with angiogenic therapy, angiocrine therapy, and protein production platforms.

1 investor

Revelen.AI uses artificial intelligence and machine learning to match ballistics evidence, helping law enforcement identify weapons and suspects and solve firearms crimes faster. Its technology relies on mobile forensics devices and AI/ML processing to deliver real-time crime intelligence for police investigations.

1 investor

Revilico builds an operating system for pharmaceutical R&D that unifies computational drug discovery tools—including molecular dynamics, quantum chemistry, generative chemistry, and virtual cell simulations—with integrated wet-lab validation. The platform serves pharmaceutical researchers and biotech companies developing small molecule drugs, covering all phases from target identification through lead optimization and preclinical development.

1 investor

Revive Environmental provides technology and services to treat and destroy PFAS ("forever chemicals") across use cases including firefighting foam (AFFF), landfill leachate, and drinking/wastewater systems. It offers on-site and off-site lifecycle remediation to help owner/operators meet PFAS discharge compliance requirements.

1 investor

Revoize builds real-time, on-device speech-to-speech infrastructure offering live translation, accent transformation, and audio quality restoration. Its cross-platform SDK targets CPaaS and unified communications platforms and device makers looking to add native real-time translation and accent normalization to audio pipelines.

1 investor

Revolve Robotics develops inspection, surveillance, and maintenance robots for hard-to-reach industrial environments, with applications in inspection, construction, security, public safety, and defense sectors. The company combines expertise in drone technology with robotics engineering to create mobile robots for previously inaccessible spaces.

1 investor

REVTECH develops and manufactures patented impact-protection materials that are customizable to a customer's design parameters, including color, weight, thickness, and flexibility. The company, which originated from research at Purdue University engineering laboratories, positions its materials as high-performance protective solutions validated by independent testing.

1 investor

Rewired (Rewired.gg) is a venture capital firm focused on the gaming and esports industry, investing in and supporting companies in that sector. It combines investment expertise with business development in video games and esports.

1 investor

RF elements manufactures wireless networking hardware components and accessories, including antennas, brackets, and mounting solutions for radio frequency applications.

1 investor

RFmondial develops hardware and software products for digital broadcasting and related industries, including transmitters, receivers, and monitoring technology based on DAB, DRM, and HD-Radio standards. The company serves global markets with research, development, and design services for the broadcasting and communications sectors.

1 investor

RFA Electric offers an autonomous analog circuit design platform that takes customer specifications through a conversational assistant and uses an autonomous engine to handle circuit design, simulation, optimization, and physical layout across millions of topologies. Its target applications include analog AI accelerators, neuromorphic architectures, autonomous vehicles, humanoid robotics, and wireless systems.

1 investor

RF Solutions designs and manufactures in-building wireless systems and equipment for life safety and telecommunications, serving enterprise and commercial building clients. The company provides engineering, design, implementation, and maintenance services to ensure reliable indoor connectivity for critical communications.

1 investor

Richmond Global Ventures is a global venture capital firm that invests in early-stage companies developing new and disruptive technologies across multiple continents. The firm also operates Smart City Technologies, which provides artificial intelligence, machine learning, and virtual reality solutions for smart cities.

1 investor

Rheon Medical develops novel surgical devices to treat glaucoma, aiming to improve treatment efficacy and reduce post-operative complications for patients. The company is a spin-off from EPFL and combines engineering expertise with clinical guidance from ophthalmology specialists.

1 investor

Rhizome Labs develops task-specific AI models that can run locally, protect sensitive data, and remain reliable in privacy-sensitive, industrial, and operationally demanding environments. The company focuses on open-source research for trustworthy, adaptive AI systems with human oversight.

1 investor

Rhovica Neuroimaging AG develops a patented navigation system for safe placement of brain catheters in acute cerebral hemorrhage cases, enabling real-time monitoring and bedside treatment in emergency settings. The company serves hospitals and emergency care providers in the medical device and neurosurgery sector.

1 investor

Ribogenyx develops first-in-class therapeutic enhancers of translational fidelity, targeting mRNA translation processes for precision medicine. Its focus is on age-related diseases and mechanisms of stress resilience mediated by mRNA translation.

1 investor

RICOS develops computational science and machine learning technology to identify and visualize manufacturing challenges, helping companies optimize design and product development processes. The company serves manufacturing organizations seeking to accelerate processes through scientific analysis and simulation-based AI.

1 investor

Ridge-i develops AI and satellite data analytics solutions for disaster prevention, forest monitoring, environmental management, and manufacturing optimization. The company serves enterprise clients and government agencies across Japan.

1 investor

Rimkus is an engineering and consulting firm providing forensic analysis, infrastructure design, and built environment solutions to owners, operators, and construction stakeholders. The company serves clients across commercial, industrial, and public sectors requiring technical expertise in building systems, construction disputes, and infrastructure planning.

1 investor

RIN Institute develops antibody-based pharmaceuticals and in vitro diagnostic drugs for medical research and clinical use. The company was spun out from Japan's National Cancer Center.

1 investor